Pemtumomab
Intraperitoneal | |
|---|---|
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
  (what is this?) (verify) | |
Pemtumomab (trade name Theragyn) is a
clinical trials.[2]
It has been granted orphan drug status in Europe.[3]
References
- S2CID 2287723.
- ^ Clinical trial number NCT00004115 for "Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy" at ClinicalTrials.gov
- ^ Antisoma's Lead Product, Pemtumomab Granted European Orphan Drug Status[dead link]
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |